Casino Machine Manufacturing Business Investment Opportunities in Riverside, California

COMPANY PROFILE. A World of Excellence in In-Vitro Diagnostic Kits & Reagents. Has a history of over 36 years in successfully developing, designing, producing, selling and marketing a complete line of diagnostics reagents and kits for use in Hospitals, Medical Laboratories, Research Institutions within the Health Care and Pharmaceutical Industries. Its strength stems from a foundation of knowledge and experience in product development with a commitment to quality and cost effectiveness in the biotechnology field. Products are developed, designed and produced with unique formulations using state-of the-art technology. All in-vitro diagnostics reagents and kits are produced using GMP rules and regulations of the USA FDA. Products are marketed in, USA and Globally. Presently it has three international branches (India, China, and Latin America) and a worldwide distribution network. Main Mission is to produce and distribute USA Made and FDA approved IVD Kits and Reagents globally. OEM, Private Label, Bulk Reagents/Components, CRO and Technology Transfer Services are available. Prestigious Clients We are very proud of our high quality FDA approved product lines, particularly, which are currently being sold to institutions such as: CDC, NIH, Prestigious Universities, Research Centers, Cancer Research Institutions, VA and other Prestigious Private Hospitals. Biotron Diagnostics has been certified as a US Government Supply Administration Federal Vendor. Products are competitively priced. Mission is to produce and distribute high quality and low cost USA Made and FDA approved IVD Kits and Reagents, offering OEM Service, Private Label, Bulk Reagents/Components, and IVD Technology Transfer in the field of Laboratory Medicine. Current Licenses: FDA Registered Establishment CFG- Free Sale (Current) California PHFDA IVD Manufacturing ISO 13485-2016 (IAS) CE Mark Certified 510 (K) s 120 C FG= List of FDA approved IVD Kits City of Hemet. Products Summary company develops, produces, provides OEM services and distributes high quality and low cost in vitro diagnostics kits and reagents for Clinical Chemistry (Routine and Research chemistries - similar to Sigma and ultra-sensitive Sickle Cell Kits & Controls) ), Immunochemistry (ELISA/CLIA), Urinalysis, Serology, Fertility, Coagulation, Blood Banking, Rapid Diagnostics, Drug Screening, Biomarkers (Tumor Markers and Cardiac Tests), Infectious Diseases Rapid Tests (Export only), Bulk Clinical Chemistry & Coagulation Reagents for Instruments, Calibrators, Controls & Standards, Diabetes (Dr. G Glucosemeter & Test Strips (Dr. G Smart 1, Dr. G Smart 2, Dr. G Smart 3) Hematology (Buffers & Reagents), Microbiology (Media, Stains and Reagents), Histology and Cytology (Buffers & Reagents), Veterinary test kits and Petnostics and Molecular Diagnostics (Genomics) Innovated Gene Testing Assays for Cancer and Infectious Diseases. Most Popular & Best Seller Popular Products include advanced Sickle Cell Kit and Sickle Cell Controls (Sensitivity correlates with Hemoglobin Electrophoresis), Biotin-Streptavidin Technology based ELISA Kits, Most advanced UroFast Urine Reagent Test Strips, Dr. G Glycosometer, Research Chemistries, Infectious Disease Rapid Tests for Export, and Temperature Stable Culture Media (up to 60°C). Specialty Products includes ultra-sensitive tests for Fertility (Novel Pregnancy Test and Male Fertility), Dr. G Glucose meters + HBA1C), Serology (Rubella, SLE, ANA, RPR, FOB, Staph A, Strep A, Febrile Antibodies Kits: febrile Kit, Widal Kit 400, Widal Kit 800, Rose Bengal Kit, Dri. Dot Kits and H Pylori), Highly Sensitive Infectious Disease Rapid Tests (Strips & Cards) for for Export only (CE Mark, WHO) for Hepatitis, Human Immunodeficiency Virus 1+2, Treponema Pallidum, Neisseria Gonorrhoeae, Helicobacter Pylori, Malaria, Cholerae Vibrio Antigen (Ogawa/Inaba), Yesinia Pestis, Plague, Tuberculosis, Adenovirus, Rotavirus, A Streptococcus, Chlamydia Trachomatis, Procalcitonin test, Salmonella Typhi, Dengue Virus, Chagas, Zika Virus, and Precise Biomarkers (CEA, FOB, AFP, PSA, Fatty Acid, Troponin I, CK-MB, Myoglobin, C-reactive Protein, BioFast COVID-19 Assays (BioFast COVID-19 Antigen Test - (Professional Use Only), BioFast COVID-19 Antigen Home TestBioFast COVID-19 Antibody Test, BioFast iAMP COVID-19 Detection Test Kit (Multiplex Fluorescent Detection) BioFast COVID-19 Antigen (Saliva) Home Test* COVID-19 IgG/IgM Antibody Test* COVID-19 IgG/IgM Antibody Test with LF Reader* COVID-19 IgG-only Antibody Test* COVID-19 & M. pneumoniae IgG/IgM Antibody Combo Test* COVID-19 & M. pneumoniae IgG-only Combo Test* COVID-19 and Influenza A/B Antigen Combo Rapid Test* COVID-19 Antigen (Saliva) Test Strip}, *SARS-COV-2 RT-qPCR Assay. Molecular Diagnostics (HPV. Fifteen high-risk types Kits both in multiplex and genotyping formats, Chlamydia Trachomatis, Clostridium Difficile, Coxiella Burnetii, Neisseria Gonorrhoeae, Yesinia Pestis, Bacillus Anthracis, Francisella Tularensis, Haemophilus, Legionella, Listeria, Salmonella, Staphylococcus and Trichomonas Vaginalis), Immunofluorescent Assays (infectious Diseases —Chagas, Toxplasmosis, Hidatidosis, Syphilis, Triquinosis, Chlamydia trachomatis, Autoimmune Diseases- Anti-DNA, ANAHEp-2, AMA, ASMA, APCA, ANA, LMK, EMAIgA0) and Plasma Proteins ¬RID- human proteins, Combo Immunoglobulins (IgA, IgG, IgM) IgA, IgG, IgM, IgD, Complement C-3 and C-4 and others and Bio-Defense related test assays are researched, developed, formulated and Produced. Newest Products) includes 1. 25 (OH) Vitamin D ELISA (VDSP) 2. Active Vitamin B12 EIA 3. Urofast URS Reagent Test Strips 11 parameters 4. HPV DNA PCR Detection Kit 5. H. pylori Antigen feces ELISA 6. D r. G Glycosometer + HbA1C Combo Meter 7 Allergy Screen 8. Ds DNA ELISA 9. Immune Health IgG ELISA 10. HIV ½ Ag/Ab 4th Generation Rapid Test 11. Calprotectin Rapid Test 12. ANA Screen IgG ELISA 13. . Zika IgM Rapid Test 14. Chikungunya IgM Combo Rapid Test 15. Chlamydia Ag Rapid Test 16. Syphilis Rapid Test 17. Influenza A/B Rapid Test 18. COVID-19 R T (Antigen) both professional and do yourself home test 19. COVID- 19 RT (Antibody) 20. COVID- 19 Multiplex PCR Detection.

Company providing fire inspection and maintenance which is mandatory as per the law for commercial buildings. - The business offers services of installation, testing, maintenance, and design of fire alarms, fire sprinklers, and fire suppression. - We are a small company competing with billion-dollar conglomerates and winning business because of our attention to the customer experience. - We would like to build a training center for our technicians and improve their skills, at the same time we would also like to invest more in our salespeople. - Single shareholder in the business with complete control.

Operates a compliant prescription-only cannabis retail distribution business in Long Beach, California. - Runs a B2C medical cannabis store catering exclusively to registered patients under California regulations. - The retail outlet operates from a leased commercial property with City of Long Beach license approvals in place. - Currently generates average daily sales of around USD 200 and has a structured plan to scale revenues to over USD 2,000 per day within the next two years. - Growth strategy includes expanding product assortment, improving patient retention, and increasing daily footfall through compliant marketing and partnerships. - Business is positioned for steady scale-up as regulatory compliance, brand presence, and repeat customer base strengthen. Operations & Compliance: - B2C retail operations with daily walk-in sales. - City of Long Beach license approved; premises are leased. - Operates in compliance with state and local cannabis regulations.

This global biotechnology company specializes in cutting-edge allogeneic adult stem cell technology, uniquely positioned as the only FDA-approved entity worldwide, with the Drug Controller General of India (DCGI) approval in process. - The company manufactures clinical-grade stem cells under cGMP standards, providing vital materials for US-based and international clinical trials, hence establishing a strong foothold in the biotechnology sector. - With Investigational New Drug Approvals for several serious conditions, including acute myocardial infarction, chronic heart failure, and Alzheimer’s disease, the company focuses on innovative solutions for chronic ailments lacking effective treatments. - Its cell-based therapies are designed to enhance longevity and quality of life, particularly targeting rehabilitation for chronic stroke patients and those affected by diseases without available cures. - Operating for 24 years in California, the business has a robust track record and is actively seeking expansion opportunities in international markets, allowing for broader reach and impact. - Revenue is generated through multiple channels, including a sale of license model with annual royalty fees averaging around 15% revenue, alongside direct sales of stem cells to existing licensees that partner with hospitals and healthcare providers. - Major license sale deals over the years include up to $529 million with South Asian countries, $72 million with a Chinese firm, $21 million with a Mexican company, $20 million with a Russian entity, and $21 million with a Kazakh company, showcasing strong demand and financial viability. - As a result of focused and aggressive marketing efforts to sell licenses, our sales have increased by a wide margin. We expect to reach an annual turnover of USD 3 billion for the next CY. - Recently registered as a public limited company in India, the firm is planning to establish a local laboratory and operations, further strengthening its market presence in the biotechnology industry. - The workforce comprises around 50 full-time employees, supplemented by freelance and interns, enhancing operational flexibility and innovation in research and development. - The promoter is currently in India and oversees operations across both locations.

US-based renewable energy company specializing in off-grid wind and water generator systems built directly at client sites. - Products include tower generators designed to generate significantly higher renewable energy output than traditional turbines. - Each unit delivers between 10,000–20,000 watts of power, catering to off-grid users and heavy electricity consumers. - Operations are fully on-site with no fixed office; structures are assembled and installed at locations with optimal wind or water flow. - Currently serving 14 customers across various locations, providing custom-built renewable energy solutions. - Holds patent strengthening the product’s uniqueness and competitive advantage. - Business is owner-operated with a team of 5, funded entirely by the founder with no loans. - Operating as an S Corporation established company.

California-based, fully remote health insurance company serving over 300 active customers. - Sells health insurance products through partnerships with 20 insurance providers. - Generates revenue through commissions, overrides, and renewals, offering recurring income potential. - Operates entirely online with digital assets including servers, website, domain, email infrastructure, databases, and proprietary IP. - Registered under FINRA, with an insurance book that can be liquidated to clear existing debt if required. - Managed by a lean team of two employees overseeing sales, renewals, and administrative functions. - Suitable for buyers with a life or health insurance license looking to acquire a ready book of business and digital infrastructure. - The owner has shifted focus to a new business and is unable to dedicate time to this one, resulting in a drop in sales compared to last year.

The mine site is a non-operational 11,000-acre gold and copper deposit located in the Toodoggone Region of Northwestern British Columbia, Canada. This area has numerous current and past operating mines. One of the largest was the nearby Kemess mine, operated by Northgate Minerals and now under expanded development by Centerra Gold Inc. - All project work has been carried out under 43-101 industry standards. - The deposit is valued at an estimated USD 15 billion. - The site has never been mined. It will require additional development capital, much of which can be financed. . - The mining rights are held in perpetuity. - The company is incorporated as a private limited entity and holds full rights to develop and mine the site.

Trusted by hundreds of families & athletes – Serving youth, adults, and teams across Santa Clarita and greater Los Angeles. Proven revenue model – Multiple streams including memberships, tournaments, leagues, recovery, camps, and sponsorships. Experienced promoters – Partnerships with top AAU, club, and league organizers bring consistent traffic and competitive play. Strong community relationships – Working with local schools, clubs, and businesses to build a true sports and wellness hub. Award-winning vision – Founded by a veteran entrepreneur, recognized for innovation and commitment to youth development. Performance + lifestyle – More than sports: recovery lounge, café/bar, and family-friendly amenities make it a destination.

The startup is in the pre-revenue stage. - The business is not yet registered, and registration will be completed based on the investor’s choice and preferred country once funding is secured. - The founder is currently based in Tustin, California. - The founder has developed a pharmaceutical formula that stops the progression of vision loss caused by age-related macular degeneration (AMD) after years of research and development. - Worldwide, there are approximately 400 million AMD sufferers. - The medicine formula has been created, and the patent is currently in process. - For major markets, the company plans to partner with a well-positioned pharmaceutical manufacturer, preferably one with existing eye-care products, for distribution. - In less developed markets, distribution will be handled directly through professional networks and online sales programs, targeting patients and their physicians. - The promoter has experience in founding and growing medical device and ophthalmic companies. - He has led multiple mergers and acquisitions and developed innovative surgical and dental technologies, including intraocular lenses and fluidics-based devices. - He is also actively engaged in pioneering research on age-related macular degeneration and non-surgical aesthetic medical procedures.